Woodline Partners »

BioCryst Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2023-03-31 $5.9M 702k 8.34
2022-12-31 $24M 2.1M 11.48
2020-12-31 $1.2M 156k 7.45
2020-09-30 $3.0M 869k 3.44
2020-06-30 $7.6M 1.6M 4.76
2020-03-31 $2.5M 1.3M 2.00
2019-12-31 $8.3M 2.4M 3.45